|
|
|
|
Edited by Philip Keefer, Norman Loayza
|
|
|
The drug policies of wealthy consuming countries emphasize
criminalization, interdiction, and eradication. Such extreme responses
to social challenges risk unintended, costly consequences. The evidence
presented in this volume is that these consequences are high in the
case of current drug policies, particularly for poor transit and
producer countries. These costs include the deaths of thousands in the
conflict between drug cartels and security forces, political
instability, and the infiltration of criminal elements into
governments, on the one hand; and increased narcotics use in countries
that would not otherwise have been targeted by drug suppliers.
Despite such costs, extreme policies could be worthwhile if their
benefits were significantly higher than those of more moderate, less
costly policies. The authors review the evidence on the benefits of
current policies and find that they are clouded in uncertainty:
eradication appears to have no permanent effect on supply; the evidence
on criminalization does not exclude either the possibility that its
effects on drug consumption are low, or that they are high. Uncertainty
over benefits and the high costs of current policies relative to
alternatives justifies greater emphasis on lower cost policies and more
conscientious and better-funded efforts to assess the benefits of all
policies.
- Shipping Weight: 1.585 lbs (0.72 kgs)
Related Products
|
|